Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report

Tumori. 2010 Jan-Feb;96(1):154-6. doi: 10.1177/030089161009600125.

Abstract

Drug-induced acute thrombocytopenia is an extremely rare side effect that may occur immediately after oxaliplatin infusion. This potentially fatal reaction is immune mediated and can be anticipated by mild hemorrhagic signs during previous administrations. This is the first report of acute thrombocytopenia occurring during adjuvant treatment of colorectal cancer with oxaliplatin. Clinicians should be aware of this adverse event in order to prevent possible serious consequences and stop further oxaliplatin administration.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / surgery
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / immunology
  • Chemotherapy, Adjuvant / adverse effects
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / surgery
  • Drug Hypersensitivity / diagnosis*
  • Drug Hypersensitivity / immunology
  • Female
  • Humans
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects*
  • Oxaliplatin
  • Platelet Transfusion
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / immunology*
  • Thrombocytopenia / therapy
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin